Who is on it, and how far along Every drug ChEMBL records acting on KCNH2, by the furthest stage it has reached for any use, coloured by modality.
How to read this Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
Approved5 Amiodarone Amiodarone SponsorPfizer ModalitySmall molecule ActionBlocker Open trials49 Sotalol Sotalol SponsorLEGACY ModalitySmall molecule ActionBlocker Open trials14 Dofetilide Dofetilide SponsorPfizer ModalitySmall molecule ActionBlocker Open trials3 Ibutilide Ibutilide SponsorPfizer ModalitySmall molecule ActionBlocker Open trials1 Vernakalant Vernakalant SponsorAstellas Pharma ModalitySmall molecule ActionBlocker Open trials1 Phase 22 AZD1305 AZD1305 SponsorAstraZeneca Pharmaceuticals ModalitySmall molecule ActionBlocker Open trials0 AZD7009 AZD7009 SponsorAstraZeneca Pharmaceuticals ModalitySmall molecule ActionBlocker Open trials0
Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials. All act as: HERG blocker. The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 18 in all, from ClinicalTrials.gov. Trial Drug Phase Status Lead sponsor First posted Artificial Intelligence-enabled Management of Atrial Fibrillation(ABLE-AF Trial) Amiodarone Not applicable Not yet recruiting Korea University Anam Hospital Nov 16, 2026 Randomized Interventional Clinical Trial on the Prevention of Atrial Fibrillation Using Colchicine, Amiodarone And a Posterior Pericardiotomy. Amiodarone Phase 3 Not yet recruiting Elsan Oct 21, 2026 Percutaneous Stellate Ganglion Block as First Line Treatment in Patients With Electrical Storm: the STAR 2 Study Amiodarone Phase 3 Not yet recruiting Fondazione IRCCS Policlinico San Matteo di Pavia Sep 25, 2026 A Study on the Efficacy and Safety of TEER Combined With Electrical Cardioversion in Patients With Severe Mitral Regurgitation and Atrial Fibrillation Amiodarone Not applicable Recruiting Second Affiliated Hospital, Zhejiang University, School of Medicine Aug 3, 2026 Efficacy of Early Rhythm Control in AF With TR Patients Amiodarone, Sotalol — Recruiting Samsung Medical Center May 26, 2026 Pulsed Field Ablation Outcomes With Efficacy and Randomization in Atrial Fibrillation (POWER-AF) Ibutilide Not applicable Recruiting China National Center for Cardiovascular Diseases May 22, 2026 Pharmacological Intervention to Prevent NOAF After TAVR Amiodarone Not applicable Not yet recruiting Shanghai East Hospital Apr 9, 2026 Comparative Efficacy of 100-, 200-, & 400-mg Amiodarone in Patients With Paroxysmal AF Depending on Plasma Concentration Amiodarone Phase 4 Enrolling by invitation Tomsk National Research Medical Center of the Russian Academy of Sciences Mar 23, 2026 Role of Combination Therapy of Glucose Insulin Potassium Infusion (GIK), Intravenous Hydrocortisone and Oral Sevelamer in Treatment of Acute Aluminum Phosphide Poisoned Cases Admitted to Intensive Care Unit (ICU) at Sohag University Hospitals. Amiodarone Not applicable Not yet recruiting Sohag University Mar 5, 2026 Catheter Ablation Versus Anti-arrhythmic Drugs for Premature Ventricular Complexes Sotalol Not applicable Recruiting Western Sydney Local Health District Mar 3, 2026 Efficacy of Early Rhythm Control Therapy in Patients With Subclinical Atrial Fibrillation Sotalol Not applicable Recruiting Samsung Medical Center Mar 3, 2026 Flecainide Safety in Patients With Coronary Artery Disease and Atrial Fibrillation Sotalol Phase 4 Recruiting Universitaire Ziekenhuizen KU Leuven Feb 12, 2026 Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control Dofetilide, Sotalol — Not yet recruiting Kansas City Heart Rhythm Research Foundation Jan 20, 2025 Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies Sotalol Not applicable Recruiting IRCCS Ospedale San Raffaele Nov 1, 2024 Prospective Multicenter Randomized and Controlled Study Evaluating the Benefit of Early Pulmonary Vein Isolation Compared to Usual Treatment in Patients Aged Over 75 Years and Presenting With Atrial Fibrillation Sotalol Not applicable Recruiting Nantes University Hospital Mar 20, 2024 Pulsed Field Ablation (PFA) vs Anti-Arrhythmic Drug (AAD) Therapy as a First Line Treatment for Persistent Atrial Fibrillation Dofetilide, Sotalol Not applicable Active, not recruiting Boston Scientific Corporation Oct 23, 2023 The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients Dofetilide Phase 4 Recruiting University of Rochester Sep 5, 2021 Vernakalant Versus Amiodarone for Post-operative Atrial Fibrillation in Cardiac Surgery Patients Vernakalant Phase 3 Not yet recruiting University of Calgary Feb 10, 2021
Diseases most associated with it Open Targets association score, 0 to 1; all associations Familial long QT syndrome 0.85 Familial long QT syndrome Value0.85 Short QT syndrome 0.78 Short QT syndrome Value0.78 Atrial fibrillation 0.74 Atrial fibrillation Value0.74 Open Cardiac arrhythmia 0.73 Cardiac arrhythmia Value0.73 Prolonged QT interval 0.71 Prolonged QT interval Value0.71 Ventricular fibrillation 0.68 Ventricular fibrillation Value0.68 Open Atrial flutter 0.61 Atrial flutter Value0.61 Open Ventricular tachycardia 0.58 Ventricular tachycardia Value0.58 Open Ventricular arrhythmia 0.57 Ventricular arrhythmia Value0.57 Abnormality of the cardiovascular system 0.57 Abnormality of the cardiovascular system Value0.57 Lambert-Eaton myasthenic syndrome 0.56 Lambert-Eaton myasthenic syndrome Value0.56 Myasthenia gravis 0.56 Myasthenia gravis Value0.56 Open Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL240 , ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov , checked daily; this page as of 2026-11-21. Gene name, function (UniProt Q12809 , CC BY 4.0) and disease associations are from Open Targets (CC0). ChEMBL and Open Targets